| Mrs Sharon G Crenshaw, PHYSICIAN EXTENDER | |
|
301 N Herman Street Box Cc, Goldsboro, NC 27530-1056 | |
| (919) 731-1250 | |
| (919) 731-1232 |
| Full Name | Mrs Sharon G Crenshaw |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 37 Years |
| Location | 301 N Herman Street Box Cc, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104932433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 102718 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Insight Family Center | 9436387362 | 2 |
News Archive
eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announced today the release of their new UHF EPC compliant MicroWing inlay. The MicroWing is the size of a paper clip which makes it the smallest RFID inlay available on the market to achieve a greater than 2 meter read range.
In a nationally representative sample of nearly 3,000 children and adolescents, those who had higher concentrations of urinary bisphenol A (BPA), a manufactured chemical found in consumer products, had significantly increased odds of being obese, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
Freestanding emergency departments may charge more than urgent care centers (UCCs) to provide care for fewer patients who have similar characteristics and conditions, according to a study released in the Journal of Emergency Medicine.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Gemcitabine HCI for Injection, USP, in the 2 g dosage strength. APP will launch this presentation of Gemcitabine immediately.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sharon G Crenshaw, PHYSICIAN EXTENDER 312 Merrywood Dr, Raleigh, NC 27610-3332 Ph: (919) 832-9129 | Mrs Sharon G Crenshaw, PHYSICIAN EXTENDER 301 N Herman Street Box Cc, Goldsboro, NC 27530-1056 Ph: (919) 731-1250 |
News Archive
eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announced today the release of their new UHF EPC compliant MicroWing inlay. The MicroWing is the size of a paper clip which makes it the smallest RFID inlay available on the market to achieve a greater than 2 meter read range.
In a nationally representative sample of nearly 3,000 children and adolescents, those who had higher concentrations of urinary bisphenol A (BPA), a manufactured chemical found in consumer products, had significantly increased odds of being obese, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
Freestanding emergency departments may charge more than urgent care centers (UCCs) to provide care for fewer patients who have similar characteristics and conditions, according to a study released in the Journal of Emergency Medicine.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Gemcitabine HCI for Injection, USP, in the 2 g dosage strength. APP will launch this presentation of Gemcitabine immediately.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
› Verified 2 days ago
John Dennis Howell Jr., PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2600 Us Highway 70 W, Goldsboro, NC 27530 Phone: 919-739-4808 | |
Christopher Mooney, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 212 N Spence Ave, Goldsboro, NC 27534 Phone: 919-778-0851 | |
Ms. Diane Lancaster Mullins, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 901 Beech St, Goldsboro, NC 27530 Phone: 919-739-8266 Fax: 919-739-8656 | |
Ashley Blaire Slate, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2604 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-580-0004 Fax: 919-580-9224 | |
Mrs. Stacey N Hill, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 | |
Kristina Kohuth, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1402 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 772-486-0807 | |
Bridgett Leigh Buckman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 |